US Archives - Page 87 of 119 - European Medical Journal

Review of IDWeek 2024

THE VIBRANT city of Los Angeles, California welcomed over 12,000 clinicians, scientists, epidemiologists, researchers, advanced practice…

Exploring Ibalizumab’s Role in HIV

Although treatment for HIV has advanced considerably over the decades, there are still people with HIV that is resistant to multiple…

Gender Differences in Hepatitis C Treatment in NYC Jail

Hepatitis C virus (HCV) care among women experiencing incarceration is rarely addressed in the literature. Although women comprise…

AMJ Microbiology & Infectious Diseases 2.1 2024

What’s redefining infectious diseases in 2024? In this issue of AMJ Microbiology & Infectious Diseases, we unpack the pivotal moments…

Cancer Screenings In HIV: Roles of Individuals and System

As persons with HIV(PWH) age, non-AIDS-defining cancers (NADC) are emerging as a leading cause of morbidity and mortality…

The Unseen Impact of Visceral Fat in HIV

While modern antiretroviral therapy (ART) for people with HIV (PWH) increases life expectancy, there is still an increased risk of…

HIV Treatment at IDWeek 2024

AT IDWeek 2024, held in Los Angeles, California, researchers converged from across the world to discuss the latest research surrounding…

Assessing HAV and HBV in HIV Within Illinois Department of Corrections

Individuals in custody face higher risks of vaccine-preventable diseases due to overcrowding, high turnover, high-risk behaviors, and…

Battling Pediatric Mold Infections: Invasive Aspergillosis and Invasive Mucormycosis

Mold species are inhaled by people every day and, typically, infection is locally curtailed by the immune system. However, in people who…

Respiratory Viral Infections: Highlights from IDWeek 2024

IDWEEK 2024, held in Los Angeles, California, October 16th–19th, was an opportunity for the >12,000 attendees to hear about…